These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 24440556)
1. PPARγ1 phosphorylation enhances proliferation and drug resistance in human fibrosarcoma cells. Pang X; Shu Y; Niu Z; Zheng W; Wu H; Lu Y; Shen P Exp Cell Res; 2014 Mar; 322(1):30-8. PubMed ID: 24440556 [TBL] [Abstract][Full Text] [Related]
2. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236 [TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells. Sung CK; She H; Xiong S; Tsukamoto H Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G722-9. PubMed ID: 14656714 [TBL] [Abstract][Full Text] [Related]
4. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth. Cheung KF; Zhao J; Hao Y; Li X; Lowe AW; Cheng AS; Sung JJ; Yu J Cancer; 2013 Mar; 119(6):1217-26. PubMed ID: 23212831 [TBL] [Abstract][Full Text] [Related]
5. Identification of a truncated alternative splicing variant of human PPARgamma1 that exhibits dominant negative activity. Kim HJ; Woo IS; Kang ES; Eun SY; Kim HJ; Lee JH; Chang KC; Kim JH; Seo HG Biochem Biophys Res Commun; 2006 Sep; 347(3):698-706. PubMed ID: 16842753 [TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes. Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086 [TBL] [Abstract][Full Text] [Related]
7. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Chen A; Xu J Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells. Zaytseva YY; Wang X; Southard RC; Wallis NK; Kilgore MW Mol Cancer; 2008 Dec; 7():90. PubMed ID: 19061500 [TBL] [Abstract][Full Text] [Related]
14. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARgamma in A549 cells. Kim HJ; Woo IS; Kang ES; Eun SY; Kim GH; Ham SA; Kim HJ; Lee JH; Chang KC; Kim JH; Lee HT; Seo HG Biochem Biophys Res Commun; 2006 Oct; 349(2):660-7. PubMed ID: 16945329 [TBL] [Abstract][Full Text] [Related]
15. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway. Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122 [TBL] [Abstract][Full Text] [Related]
16. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291 [TBL] [Abstract][Full Text] [Related]
18. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Chang BD; Xuan Y; Broude EV; Zhu H; Schott B; Fang J; Roninson IB Oncogene; 1999 Aug; 18(34):4808-18. PubMed ID: 10490814 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis. Joshi PP; Kulkarni MV; Yu BK; Smith KR; Norton DL; van Veelen W; Höppener JW; Franklin DS Oncogene; 2007 Jan; 26(4):554-70. PubMed ID: 16953232 [TBL] [Abstract][Full Text] [Related]
20. Stable reporter cell lines for peroxisome proliferator-activated receptor γ (PPARγ)-mediated modulation of gene expression. Gijsbers L; Man HY; Kloet SK; de Haan LH; Keijer J; Rietjens IM; van der Burg B; Aarts JM Anal Biochem; 2011 Jul; 414(1):77-83. PubMed ID: 21354099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]